Madrigal Pharmaceuticals
Trade Madrigal Pharmaceuticals 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MDGL
Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia.
MDGL Key Statistics
Stock Snapshot
The current Madrigal Pharmaceuticals(MDGL) stock price is $556.22, with a market capitalization of 12.61B. The stock trades at a price-to-earnings (P/E) ratio of -43.14.
During the trading session on 2026-01-08, Madrigal Pharmaceuticals(MDGL) shares reached a daily high of $568.00 and a low of $547.90. At a current price of $556.22, the stock is +1.5% higher than the low and still -2.1% under the high.
Trading activity shows a volume of 264.43K, compared to an average daily volume of 276.15K.
The stock's 52-week range extends from a low of $265.00 to a high of $615.00.
The stock's 52-week range extends from a low of $265.00 to a high of $615.00.
MDGL News
Earlier this week, Wolfe Research analyst Andy Chen downgraded Madrigal Pharmaceuticals from buy to hold, arguing the company’s valuation looks rich relative to...
